Related references
Note: Only part of the references are listed.Osteopontin Promotes the Invasive Growth of Melanoma Cells by Activating Integrin αvβ3 and Down-Regulating Tetraspanin CD9
Miao Yin et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
mTOR activation in medullary thyroid carcinoma with RAS mutation
Joana Lyra et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence
Fernando Ortiz-Martinez et al.
HUMAN PATHOLOGY (2014)
Role of osteopontin in the pathophysiology of cancer
Lalita A. Shevde et al.
MATRIX BIOLOGY (2014)
Survivin Delta Ex3 Overexpression in Thyroid Malignancies
Joanna Waligorska-Stachura et al.
PLOS ONE (2014)
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation
Cinzia Puppin et al.
ENDOCRINE (2014)
Current Update on Medullary Thyroid Carcinoma
Dhakshinamoorthy Ganeshan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways
E. R. Gimba et al.
CANCER LETTERS (2013)
Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer
Hui-Chuan Cheng et al.
CARCINOGENESIS (2013)
Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics
Kyung Ho Kang
JOURNAL OF THE KOREAN SURGICAL SOCIETY (2013)
Osteopontin Expression is Associated with Improved Survival in Patients with Pancreatic Adenocarcinoma
Amy L. Collins et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells
Tatiana M. Tilli et al.
PROSTATE (2012)
Intracellular osteopontin (iOPN) and immunity
Makoto Inoue et al.
IMMUNOLOGIC RESEARCH (2011)
Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis
Jian Guang Lu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
High Prevalence of RAS Mutations in RET-Negative Sporadic Medullary Thyroid Carcinomas
Margarida M. Moura et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Correlation Between Osteopontin Messenger RNA Expression and Microcalcification Shown on Sonography in Papillary Thyroid Carcinoma
Yongmei Sun et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2011)
Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression
Tatiana M. Tilli et al.
MOLECULAR CANCER RESEARCH (2011)
Bone matrix mRNA expression in differentiating fetal bovine osteoblasts
Kyomi Ibaraki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity
Justin D. Blasberg et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer
Chandra M. V. Goparaju et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Regulation of T-helper-cell lineage development by osteopontin: the inside story
Harvey Cantor et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells
Mari L. Shinohara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Osteopontin expression in normal skin and non-melanoma skin tumors
Pi-Ling Chang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Large cell neuroendocrine carcinoma of the lung with calcification and expression of osteopontin
Naoto Kuroda et al.
MEDICAL MOLECULAR MORPHOLOGY (2007)
A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth
G. Denning et al.
ONCOGENE (2007)
A constitutive endogenous osteopontin production is important for macrophage function and differentiation
Tobias Nystrom et al.
EXPERIMENTAL CELL RESEARCH (2007)
Essential role for nuclear PTEN in maintaining chromosomal integrity
Wen Hong Shen et al.
CELL (2007)
Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma
Cristiane A. Dalla-Torre et al.
BMC CANCER (2006)
The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation
Ji-Hyun Chung et al.
HUMAN MOLECULAR GENETICS (2006)
An osteopontin splice variant induces anchorage independence in human breast cancer cells
B He et al.
ONCOGENE (2006)
Increased expression of osteopontin contributes to the progression of prostate cancer
AC Khodavirdi et al.
CANCER RESEARCH (2006)
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness
V Guarino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Osteopontin induces multiple changes in gene expression that reflect the six hallmarks of cancer in a model of breast cancer progression
AC Cook et al.
MOLECULAR CARCINOGENESIS (2005)
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells
MD Castellone et al.
ONCOGENE (2004)
Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: Evidence of a role for an intracellular form of osteopontin
BQ Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies
D Coppola et al.
CLINICAL CANCER RESEARCH (2004)
Early malignant progression of hereditary medullary thyroid cancer
A Machens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility
T Sugatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma
N Bhattacharyya
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2003)
Transcriptional regulation of osteopontin and the metastatic phenotype: Evidence for a Ras-activated enhancer in the human OPN promoter
DT Denhardt et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts
K Suzuki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Share Paper
